Evidence map›Paper›PMID 39727170›Full record

ArticleNucleic acids research2025

Comprehensive mapping of genetic variation at Epromoters reveals pleiotropic association with multiple disease traits.

Jing Wan, Antoinette van Ouwerkerk, Jean-Christophe Mouren, Carla Heredia, Lydie Pradel, Benoit Ballester, Jean-Christophe Andrau, Salvatore Spicuglia

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Pleiotropic effects of cis-regulatory mutations.Nature reviews. Genetics · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jing WanAix-Marseille University, INSERM, TAGC, UMR 1090 Marseille, France.
Antoinette van OuwerkerkAix-Marseille University, INSERM, TAGC, UMR 1090 Marseille, France.
Jean-Christophe MourenAix-Marseille University, INSERM, TAGC, UMR 1090 Marseille, France.
Carla HerediaInstitut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, UMR 5535, Montpellier, France.
Lydie PradelAix-Marseille University, INSERM, TAGC, UMR 1090 Marseille, France.
Benoit BallesterAix-Marseille University, INSERM, TAGC, UMR 1090 Marseille, France.ORCID 0000-0002-0834-7135
Jean-Christophe AndrauInstitut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, UMR 5535, Montpellier, France.
Salvatore SpicugliaAix-Marseille University, INSERM, TAGC, UMR 1090 Marseille, France.ORCID 0000-0002-8101-7108

Funding

Agence Nationale pour la Recherche ANR-23-CE12-0008-01Aix-Marseille UniversityFRM SPF202005011917Innovative Training Network 'Molecular Basis of Human Enhanceropathies' 860002Institut National de la Santé et de la Recherche MédicaleLigue Contre le CancerMarseille Institute of Rare DiseasesMSCA Eprom-101065610
6 · The paper itself

Abstract

There is growing evidence that a wide range of human diseases and physiological traits are influenced by genetic variation of cis-regulatory elements. We and others have shown that a subset of promoter elements, termed Epromoters, also function as enhancer regulators of distal genes. This opens a paradigm in the study of regulatory variants, as single nucleotide polymorphisms (SNPs) within Epromoters might influence the expression of several (distal) genes at the same time, which could disentangle the identification of disease-associated genes. Here, we built a comprehensive resource of human Epromoters using newly generated and publicly available high-throughput reporter assays. We showed that Epromoters display intrinsic and epigenetic features that distinguish them from typical promoters. By integrating Genome-Wide Association Studies (GWAS), expression Quantitative Trait Loci (eQTLs) and 3D chromatin interactions, we found that regulatory variants at Epromoters are concurrently associated with more disease and physiological traits, as compared with typical promoters. To dissect the regulatory impact of Epromoter variants, we evaluated their impact on regulatory activity by analyzing allelic-specific high-throughput reporter assays and provided reliable examples of pleiotropic Epromoters. In summary, our study represents a comprehensive resource of regulatory variants supporting the pleiotropic role of Epromoters.

Indexed as

Enhancer Elements, GeneticGenetic PleiotropyPromoter Regions, GeneticChromatinDiseaseEpigenesis, GeneticGenetic Predisposition to DiseaseGenetic VariationGenome-Wide Association StudyHumansPolymorphism, Single NucleotideQuantitative Trait LociChromatin

Identifiers

PMID39727170
PMCPMC11879118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.